• Stereospecific 3-(2-methoxy-5-pyridyl)-alanine Modifications

  2026-07-30

  This study explores the incorporation of 3-(2-methoxy-5-pyridyl)-alanine at position 3 in degarelix-based GnRH antagonists, revealing significant stereochemistry-dependent effects on receptor antagonism and pharmacological duration. The findings provide actionable insights for peptide drug design and deepen our understanding of how unnatural amino acid substitutions modulate endocrine signaling.

• NADPH Oxidase-ROS Activate L-Type Ca2+ Channels in Arterial

  2026-07-30

  This study elucidates how NADPH oxidase-derived reactive oxygen species (ROS) induce arterial contraction in early postnatal rats through activation of L-type voltage-gated calcium channels, independently of Rho-kinase, PKC, or Src-kinase pathways. These findings refine our understanding of vascular signaling in developing organisms and have implications for experimental design in kinase inhibitor and cell signaling pathway research.

• HBsAg Hijacks TBK1 to Suppress Interferon and Induce Autopha

  2026-07-29

  This study uncovers how hepatitis B surface antigen (HBsAg) manipulates TANK-binding kinase 1 (TBK1) to suppress type I interferon production and trigger early autophagy, facilitating persistent HBV infection. The findings reveal a novel mechanism of immune evasion and highlight potential targets for antiviral intervention.

• Aurora Kinase A Overexpression in Retinoblastoma: Therapeuti

  2026-07-29

  A recent study demonstrates that Aurora kinase A (AURKA) is consistently overexpressed in human retinoblastoma and closely correlates with histopathological high-risk factors and suboptimal chemotherapy response. These findings provide a strong rationale for targeting AURKA as a therapeutic strategy, particularly in advanced or refractory retinoblastoma.

• Protoporphyrin IX: Precision Tool for Ferroptosis and Heme R

  2026-07-28

  Explore how Protoporphyrin IX empowers advanced studies in ferroptosis, heme formation, and photodynamic therapy. This in-depth guide reveals unique assay strategies and translational insights for researchers leveraging this pivotal photodynamic compound.

• Tyrothricin Peptide Antibiotic: Unraveling Advanced Antimicr

  2026-07-28

  Explore the unique antimicrobial peptide mechanism of action of Tyrothricin—a peptide antibiotic mixture—through an in-depth scientific lens. This cornerstone article delivers a fresh perspective on membrane disruption, cross-kingdom efficacy, and practical research approaches, setting it apart from existing resources.

• Azithromycin as a Senolytic: Targeting Senescent Fibroblasts

  2026-07-27

  Ozsvari et al. identify Azithromycin, a macrolide antibiotic, as a potent senolytic agent that selectively eliminates senescent human fibroblasts. This work highlights the drug's unique metabolic and autophagic effects on senescent cells, offering new directions for aging and cellular senescence research.

• Drug-Sensitized Yeast Platform for mTOR Inhibitor Discovery

  2026-07-27

  This study introduces a yeast-based, drug-sensitized screening platform that dramatically increases the sensitivity for detecting mTOR inhibitors, enabling identification of compounds affecting TOR signaling at nanomolar concentrations. The approach offers a significant advance in drug discovery for geroprotective and anti-cancer research, with robust evidence for selectivity and workflow applicability.

• Butylhydroxyanisole (BHA) in Advanced ROS Modulation Assays

  2026-07-26

  Explore how butylated hydroxyanisole (BHA) enables next-generation oxidative stress and ROS modulation studies, with a focus on practical assay design, mechanistic insights, and the pivotal role of stereochemical innovation in peptide research.

• Azathramycin A as a Precision Tool for Ribosomal Pathway Eng

  2026-07-25

  Explore how Azathramycin A, a macrolide antibiotic, enables advanced manipulation and study of ribosomal pathways in Mycobacterium tuberculosis. This article offers a unique systems-level perspective on leveraging Azathramycin A for antibacterial assay innovation and resistance pathway modeling.

• Neuroinflammatory CGRP/SP-Piezo2–Ca2+ Axis Drives Allodynia

  2026-07-24

  Liao et al. reveal that chronic trigeminal nerve root compression induces a neuroinflammatory cascade, promoting mechanical allodynia via a Ca2+-CGRP/SP-Piezo2 axis. This study establishes a mechanistic link between neuropeptide signaling, mechanosensation, and peripheral sensitization, offering new experimental targets for trigeminal neuralgia research.

• Optimizing RNA Workflows with HyperScribe T7 High Yield RNA

  2026-07-24

  The HyperScribe T7 High Yield RNA Synthesis Kit Plus empowers researchers to generate capped, labeled, or biotinylated RNA at exceptional yields, streamlining in vitro transcription for mRNA therapies and functional genomics. This guide details experimental best practices, troubleshooting strategies, and real-world use-cases—highlighting its transformative role in BHD syndrome mRNA rescue and beyond.

• N1-Methyl-Pseudouridine-5'-Triphosphate: Advancing mRNA Tran

  2026-07-23

  This thought-leadership article unpacks how N1-Methyl-Pseudouridine-5'-Triphosphate (N1-Methylpseudo-UTP) is revolutionizing mRNA stability and translation efficiency. Integrating mechanistic insights, recent experimental breakthroughs, and translational applications, it offers actionable guidance for researchers navigating the evolving landscape of RNA therapeutics and vaccine innovation. The article draws on recent studies and competitive intelligence to provide a strategic perspective beyond conventional product summaries.

• Pharmacokinetics of Corydalis saxicola Alkaloids in MASH Mod

  2026-07-23

  This study elucidates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of major alkaloids from Corydalis saxicola Bunting. By linking disease-induced changes in drug metabolism and transporter expression, the findings provide a mechanistic basis for rationalizing clinical dosing strategies in MASLD/MASH treatment.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-07-22

  Wang et al. (2024) identify the METTL16-SENP3-LTF axis as a key regulator of ferroptosis resistance and tumorigenesis in hepatocellular carcinoma (HCC). Their findings highlight novel mechanisms of iron metabolism and present molecular targets for sensitizing HCC to ferroptosis-based therapies.

7963 records 5/531 page Previous Next 12345 下5页 Last page